‘ IQIDOE

UUID.:ggéiﬂ‘lg- 259736-4571?53:4-1SA5CC2RSBe4DBa : F} f wwmmy b 1.0.)
III IIIIIIIIIIII||I|||||||||||||||||II|||II|IIIIIIII||II|R|I|||I|I|cl|m1| mgxmwuwﬂymd 8 (1301/5
||| |||I||||||||||||||||II|||I|II|IIIIIIIIIIIIIIIII|IIIIII||||I|| M J’w'
|||I|||IIIIIIIII|||||||||||||||||||II||||||||IIIIII||||||IIIIIII Site, 2 CW M66 Q. 55 P;

(MM/DDIYYYY) W “317/ 1 d4

PATHOLOGY REPORT:
PRIMARY SITE: Cervix
1- “Biopsy of uterine cervix”:
Mucinous adenocarcinoma, invasive, papillary pattern of high grade.

6w 773$" “05 MW‘LJL WW" PW
Tés dic 002W W

(251

 

Initials Reviewed:

 

 

 

woo
TCGA Pathologic Diagnosis Discrepancy Form

 

 

 

 

 

W5; The TCGA Pathologic Diagnosis Discrepancy Form should be completed when the pathologic diagnosis
documented on the initial pathology report for a case submitted for TCGA is inconsistent with the diagnosis provided on the

Case Quality Control Form compietedfar the submitted case.

 

 

 

Tissue Source Site USS): TSS Identiﬁer: TSS Unique Patient identiﬁer: ﬂ

 

 

 

 

 

Com Ieted B Interviewer Name on OpenClinico : Com Ieted Date:
—_——-— P
{Diagnosis Information
it Data Element Entry Alternatives Working Instructions
-* _ p ' Provide ihe diagnosis] histologic cahtypeis) dncuiziented an
Parhologic Diagnosis Invaswe mucmous adonocarcmomu the initial pathology report for this case. (EL-he histology for
1 Provided on InitiaI m this vase is mixed. provide all Ilsted subtypes.
Pathology Report
. . V i’mvhle the histoiogic features selecoed on the TCGA Case
31113:??? fig/2:311? Invasive mucinous adenocarcinoma Quality Conn-oi Form complebed for this case.
' , ' m e
2 a f V
for .1 (ISA, as reﬂected of cndooervical type
on the CQCF.

 

 

 

[Discrepancy between Pathology Report and Case Quality Control Form

 

Provide a reason describing why the diagnosis on the initial

3 Provide the reason for .
pathoiogy report lar this case is not consistent with the

misotjetgztgihol ogy Case was reviewed based on the top slide diagnosis selected oniheTCLiA Case Quality Control Form.
report and the TCGA sent to BCR

Case Quality Control ' '

Form.

 

Name of 'I'SS Reviewing Provide the name ofthe pathologist who reviewed this case
4 Pathologist or Ior FCC/y

Biorepository Director

 

 

 

 

 

 

I acknowledge that the above information provided by my Institution is true and correct and has been quality controlled.

 

‘l‘SS Reviewing Pathologist or Biorepository Director Date

I acknowledge that the above information provided by my institution is (me and correct and has been quality controlled The Attending Pathologist or tho
ﬂopamnenc Chairman,.has been informed or m aware althe above discrepancy in diagnoses.

PrinoipaI Investigator Signature Date‘

